Template:Verapamil: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..."
 
Abdurahman Khalil (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 46: Line 46:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release warnings |Warnings ]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release precautions|Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release adverse reactions|Adverse Reactions]]
Line 61: Line 63:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release how supplied storage and handling|How Supplied/Storage and Handling]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release labels and packages|Labels and Packages]]
Line 80: Line 78:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection warnings|Warnings]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection precautions| Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection adverse reactions|Adverse Reactions]]
Line 95: Line 95:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil Hydrochloride injection nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil Hydrochloride injection nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection how supplied storage and handling|How Supplied/Storage and Handling]]

Latest revision as of 00:11, 5 March 2014